These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23678452)

  • 1. Inhibition of MEK/ERK1/2 Signaling Affects the Fatty Acid Composition of HepG2 Human Hepatic Cell Line.
    Yousefi B; Darabi M; Baradaran B; Shekari Khaniani M; Rahbani M; Darabi M; Fayezi S; Mehdizadeh A; Saliani N; Shaaker M
    Bioimpacts; 2012; 2(3):145-50. PubMed ID: 23678452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma.
    Wiesenauer CA; Yip-Schneider MT; Wang Y; Schmidt CM
    J Am Coll Surg; 2004 Mar; 198(3):410-21. PubMed ID: 14992744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
    Tsai J; Qiu W; Kohen-Avramoglu R; Adeli K
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fibroblast growth factor receptor 2-mediated extracellular signal-regulated kinase 1/2 signaling pathway plays is important in regulating excision repair cross-complementary gene 1 expression in hepatocellular carcinoma.
    Chen G; Qiu H; Ke S; Hu S; Yu S; Zou S
    Biomed Rep; 2013 Jul; 1(4):604-608. PubMed ID: 24648994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A activates human hepatocellular carcinoma (HepG2 cells) proliferation: implication of EGFR-mediated ERK1/2 signaling pathway.
    Abo-El Fetoh ME; Helal GK; Saleh IG; Ewees M; ElShafey M; Elnagar MR; Akool ES
    Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):897-908. PubMed ID: 31907582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARγ agonist-induced alterations in Δ6-desaturase and stearoyl-CoA desaturase 1: Role of MEK/ERK1/2 pathway.
    Saliani N; Darabi M; Yousefi B; Baradaran B; Khaniani MS; Darabi M; Shaaker M; Mehdizadeh A; Naji T; Hashemi M
    World J Hepatol; 2013 Apr; 5(4):220-5. PubMed ID: 23671727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of mitogen-activated protein kinase phosphatase-1 expression by extracellular signal-related kinase-dependent and Ca2+-dependent signal pathways in Rat-1 cells.
    Cook SJ; Beltman J; Cadwallader KA; McMahon M; McCormick F
    J Biol Chem; 1997 May; 272(20):13309-19. PubMed ID: 9148952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette smoke exposure reveals a novel role for the MEK/ERK1/2 MAPK pathway in regulation of CFTR.
    Xu X; Balsiger R; Tyrrell J; Boyaka PN; Tarran R; Cormet-Boyaka E
    Biochim Biophys Acta; 2015 Jun; 1850(6):1224-32. PubMed ID: 25697727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease.
    Wang Z; Yao T; Song Z
    J Lipid Res; 2010 Nov; 51(11):3158-65. PubMed ID: 20739640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1/2 signaling.
    Schattenberg JM; Wang Y; Rigoli RM; Koop DR; Czaja MJ
    Hepatology; 2004 Feb; 39(2):444-55. PubMed ID: 14767997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of protein kinase B, the key enzyme in insulin-signaling cascade, is enhanced in linoleic and arachidonic acid-treated HT29 and HepG2 cells.
    Mariniello K; Min Y; Ghebremeskel K
    Nutrition; 2019 Jan; 57():52-58. PubMed ID: 30153579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK1/2 contributes negative regulation to STAT3 activity in HSS-transfected HepG2 cells.
    Tian ZJ; An W
    Cell Res; 2004 Apr; 14(2):141-7. PubMed ID: 15115615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of ERK1/2 Signaling Pathway Inhibitor PD98059 on the Expression of Ras, BRaf, MEK, ERK1/2 in Marrow Nucleated Red Blood Cells of CMS Patients].
    Han YF; Ji LH; Feng TT; Liu F; Cui S; Su J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1571-1575. PubMed ID: 29070145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
    Wen-Sheng W
    Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linoleic acid induces proinflammatory events in vascular endothelial cells via activation of PI3K/Akt and ERK1/2 signaling.
    Hennig B; Lei W; Arzuaga X; Ghosh DD; Saraswathi V; Toborek M
    J Nutr Biochem; 2006 Nov; 17(11):766-72. PubMed ID: 16563718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.